Innovative pharmaceutical concept stocks rose in the early trading session, with BeiGene's shares surging over 6%.

Concept stocks of innovative drugs started to rise, with Rongchang Biology up over 14%, Yipin Hong and Jincheng Medicine up over 7%, Junshi Biology and BeiGene up over 6%, and Bailing Tianheng and Kangchen Medicine following suit.